Cite
Adjuvant Trastuzumab with or without Chemotherapy in Stage 1 pT1N0 HER2+ Breast Cancer: A National Cancer Database Analysis
MLA
Lifen Cao, et al. Adjuvant Trastuzumab with or without Chemotherapy in Stage 1 PT1N0 HER2+ Breast Cancer: A National Cancer Database Analysis. Aug. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b6f2ff283cf83aad9d30648ea285139&authtype=sso&custid=ns315887.
APA
Lifen Cao, Alberto J. Montero, Nickolas Stabellini, Christopher W. Towe, Robert Shenk, & Megan E. Miller. (2021). Adjuvant Trastuzumab with or without Chemotherapy in Stage 1 pT1N0 HER2+ Breast Cancer: A National Cancer Database Analysis.
Chicago
Lifen Cao, Alberto J. Montero, Nickolas Stabellini, Christopher W. Towe, Robert Shenk, and Megan E. Miller. 2021. “Adjuvant Trastuzumab with or without Chemotherapy in Stage 1 PT1N0 HER2+ Breast Cancer: A National Cancer Database Analysis,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2b6f2ff283cf83aad9d30648ea285139&authtype=sso&custid=ns315887.